Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Front Cell Infect Microbiol. 2021 Dec 8:11:813442. doi: 10.3389/fcimb.2021.813442. eCollection 2021.

Abstract

[This corrects the article DOI: 10.3389/fcimb.2021.716436.].

Keywords: PCR; SARS-CoV-2; biosafety; clinical diagnosis; high throughput; laboratory-acquired infection.

Publication types

  • Published Erratum